Panaxia Labs Israel Ltd
Panaxia Pharmaceutical Industries Ltd provides pharmaceutical solutions for patients and physicians. The company offers pharma-grade smokeless cannabis products, such as oral and sublingual tablets, medical oils, concentrations, pastilles, suppositories, topical creams, pain relief creams, and pain relief patches. Panaxia Pharmaceutical Industries Ltd has strategic partnerships with Ultra Health,… Read more
Market Cap & Net Worth: Panaxia Labs Israel Ltd (HROD)
Panaxia Labs Israel Ltd (TA:HROD) has a market capitalization of $108.37K (ILA40.42 Million) as of March 18, 2026. Listed on the TA stock exchange, this Israel-based company holds position #40687 globally and #373 in its home market, demonstrating a -22.98% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Panaxia Labs Israel Ltd's stock price ILA4444.00 by its total outstanding shares 9096 (9.10K).
Panaxia Labs Israel Ltd Market Cap History: 2015 to 2026
Panaxia Labs Israel Ltd's market capitalization history from 2015 to 2026. Data shows growth from $3.61K to $108.37K (38.18% CAGR).
Panaxia Labs Israel Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Panaxia Labs Israel Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of HROD by Market Capitalization
Companies near Panaxia Labs Israel Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to Panaxia Labs Israel Ltd by market ranking:
- BERKSHIRE HATH-A - Dusseldorf Stock Exchang (DU:BRH): Ranked #2321 globally with a market cap of $6.45 Billion USD ( €6.29 Billion EUR).
- BERKSHIRE HATH-A (BE:BRH): Ranked #2330 globally with a market cap of $6.40 Billion USD ( €6.24 Billion EUR).
- Itissalat Al-Maghrib (IAM) S.A (PINK:MAOTF): Ranked #3752 globally with a market cap of $3.25 Billion USD.
- NET ONE SYSTEMS (MU:NOX): Ranked #4657 globally with a market cap of $2.24 Billion USD ( €2.18 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #2321 | BERKSHIRE HATH-A - Dusseldorf Stock Exchang | DU:BRH | $6.45 Billion | €638000.00 |
| #2330 | BERKSHIRE HATH-A | BE:BRH | $6.40 Billion | €634500.00 |
| #3752 | Itissalat Al-Maghrib (IAM) S.A | PINK:MAOTF | $3.25 Billion | $14.80 |
| #4657 | NET ONE SYSTEMS | MU:NOX | $2.24 Billion | €1000000.00 |
Panaxia Labs Israel Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Panaxia Labs Israel Ltd's market cap moved from $3.61K to $ 108.37K, with a yearly change of 38.18%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ILA108.37K | -1.24% |
| 2025 | ILA109.74K | -23.05% |
| 2024 | ILA142.61K | +3848.68% |
| 2023 | ILA3.61K | +696.24% |
| 2022 | ILA453.58 | -80.42% |
| 2021 | ILA2.32K | -64.15% |
| 2020 | ILA6.46K | +0.38% |
| 2019 | ILA6.44K | -33.16% |
| 2018 | ILA9.63K | +217.78% |
| 2017 | ILA3.03K | -20.12% |
| 2016 | ILA3.79K | +5.21% |
| 2015 | ILA3.61K | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Panaxia Labs Israel Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $108.37K USD |
| MoneyControl | $108.37K USD |
| MarketWatch | $108.37K USD |
| marketcap.company | $108.37K USD |
| Reuters | $108.37K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.